Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells
Limited information is available concerning the involvement of growth factor receptors and their ligands in the pathogenesis of human pancreatic cancer. We analyzed 12 human pancreatic cancer cell lines by Northern blot analysis for the expression of 9 receptor tyrosine kinases (RTKs) and 6 growth factors. The effect of a monoclonal antibody (MAb) against transforming growth factor-α (TGF-α) on in vitro pancreatic cancer cell growth was also assessed. mRNA for EGF-R, c-erbB-2 and c-erbB-3 was expressed in 12 (100%), 12 (100%), and 7 (58%), respectively, of the cell lines examined. In addition, 8 (67%) cell lines expressed the c-met/receptor for hepatocyte growth factor. As for ligands, TGF-α mRNA was detected in 10 (83%) cell lines; MAb against TGF-α inhibited growth of the 2 cell lines examined. Furthermore, mRNA for amphiregulin (AR) was expressed in 10 (83%) cell lines. Coexpression of TGF-α, AR, and EGF-R was observed in 9 (75%) cell lines. These results support the concept that several specified types of RTKs and their ligands are closely involved in regulation of the growth of human pancreatic cancer cells.
Key WordsPancreatic cancer receptor tyrosine kinase autocrine growth factor transforming growth factor-α amphiregulin hepatocyte growth factor
Unable to display preview. Download preview PDF.
- 3.Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger A, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.Nature 1984; 309: 418–425.PubMedCrossRefGoogle Scholar
- 9.Nagata N, Akatsu T, Kugai N, Yasutomo Y, Kinoshita T, Kosano H, Shimauchi T, Takatani O, Ueyama Y. The tumor cells (FA-6) established from a pancreatic cancer associated with humoral hypercalcemia of malignancy: a simultaneous production of parathyroid hormone-like activity and transforming growth factor activity.Endocrinol Jpn 1989; 36: 75–85.PubMedGoogle Scholar
- 13.Kuribayashi K, Hikata M, Hiraoka O, Miyamoto C, Furuichi Y. A rapid and efficient purification of poly(A)-mRNA by oligo(dT)30-latex.Nucleic Acids Res Symp Ser 1988; 19: 61–64.Google Scholar
- 21.Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location withneu oncogene.Science 1985; 230: 1132–1139.PubMedCrossRefGoogle Scholar
- 30.Sambrook J, Fritsch EF, Maniatis T.Molecular Cloning, a Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.Google Scholar
- 36.Ohashi Y, Motokura M, Kinoshita Y, Mano T, Watanabe H, Kinoshita S, Manabe R, Oshiden K, Yanaihara C. Presence of epidermal growth factor in human tears.Invest Opthalmol Vis Sci 1989; 30: 1879–1882.Google Scholar
- 38.Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T, Daikuhara Y. Levels of the human hepatocyte growth factor in serum of patients with various liver disease determined by an enzyme-linked immunosorbent assay.Hepatology 1991; 13: 1–5.PubMedGoogle Scholar
- 43.Korc M, Chandrasekar B, Yamanaka Y, Friess H, Buchler M, Beger G. Overexpression of epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.J Clin Invest 1992; 90: 1352–1360.PubMedCrossRefGoogle Scholar
- 53.Smith JJ, Derynck R, Korc M. Production of transforming growth factor α in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.Proc Natl Acad Sci USA 1987; 84: 7657–7570.Google Scholar
- 62.Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met oncogene product.Nature 1991; 251: 802–804.Google Scholar